Effect of aleglitazar on cardiovascular outcomes after acute coronary syndrome in patients with type 2 diabetes mellitus: the AleCardio randomized clinical trial
… has not been associated with hypoglycemia, these agents increase the propensity for hypoglycemia when used in conjunction with insulin or sulfonylureas. Hypoglycemia resulting in …..... Read More